NASDAQ:RNTX | Free Cash Flow | Rein Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.42M
2025-12-31-$3.22M
2025-03-31-$6.18M
2024-12-31-$4.81M
2024-03-31-$5.27M
2023-12-31-$10.39M
2023-03-31-$4.66M
2022-12-31-$4.41M
2022-03-31-$7.8M
2021-12-31-$6.26M$0.00-$6.26M
2021-03-31-$6.48M$85,000.00-$6.56M
2020-12-31-$4.69M$0.00-$4.69M
2020-03-31-$5.67M
2019-12-31-$6.31M$15,000.00-$6.32M
2019-03-31-$7.5M$127,000.00-$7.63M
2018-12-31-$6.66M$1.93M-$8.6M
2018-03-31-$6.93M$7,000.00-$6.94M
2017-12-31-$5.84M$68,000.00-$5.91M
2017-03-31-$5.95M$38,000.00-$5.99M
2016-12-31-$4.23M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$19.36M
2024-12-31-$22.29M
2023-12-31-$19.81M
2022-12-31-$24.87M
2021-12-31-$23.75M$157,000.00-$23.91M
2020-12-31-$20.48M$5,000.00-$20.48M
2019-12-31-$26.47M$151,000.00-$26.63M
2018-12-31-$27.93M$4.42M-$32.35M
2017-12-31-$20.53M$142,000.00-$20.67M
2016-12-31-$15.01M
2015-12-31-$11.71M$94,000.00-$11.8M